QUEST DIAGNOSTICS INC (DGX) Insider Transactions
Explore official ownership filings, with every record linked to its source.
DGX · QUEST DIAGNOSTICS INC
How to read this data ↗View six-calendar-month insider history →
Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-21Filed 2026-10-23 | KUPPUSAMY KARTHIKOfficer · SVP, Clinical SolutionsFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. F2 The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. F3 These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under the Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date. References: F1, F2 | L Other reported codeCommon Stock · Non-derivative | 33A | 235.944 | Direct | Form 4 ↗0001022079-26-000113 |
| 2026-10-21Filed 2026-10-23 | Gregg Vicky BDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. References: F1 | A Award / grantCommon Stock · Non-derivative | 63A | 235.939 | Direct | Form 4 ↗0001022079-26-000114 |
| 2026-10-21Filed 2026-10-23 | SAMAD SAMOfficer · Executive Vice President & CFOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. References: F1 | A Award / grantCommon Stock · Non-derivative | 90A | 235.939 | Direct | Form 4 ↗0001022079-26-000115 |
| 2026-10-21Filed 2026-10-23 | CARTER ROBERT BDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. References: F1 | L Other reported codeCommon Stock · Non-derivative | 10A | 235.93 | Direct | Form 4 ↗0001022079-26-000116 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.